Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Flexion Therapeutics (FLXN)

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 462,370
  • Shares Outstanding, K 38,563
  • Annual Sales, $ 72,960 K
  • Annual Income, $ -149,770 K
  • 60-Month Beta 2.10
  • Price/Sales 6.43
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.77
  • Number of Estimates 3
  • High Estimate -0.51
  • Low Estimate -0.95
  • Prior Year -0.96
  • Growth Rate Est. (year over year) +19.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.68 +12.29%
on 06/11/20
13.57 -11.64%
on 07/01/20
+0.11 (+0.93%)
since 06/10/20
3-Month
7.52 +59.44%
on 04/16/20
13.57 -11.64%
on 07/01/20
+3.15 (+35.63%)
since 04/09/20
52-Week
5.01 +139.32%
on 03/18/20
22.98 -47.82%
on 12/27/19
+0.86 (+7.73%)
since 07/10/19

Most Recent Stories

More News
Uptrend Call Working As Flexion Therapeu Stock Rises 62.8% (FLXN)

SmarTrend identified an Uptrend for Flexion Therapeu (NASDAQ:FLXN) on March 25th, 2020 at $7.68. In approximately 4 months, Flexion Therapeu has returned 62.76% as of today's recent price of $12.50.

FLXN : 11.99 (-1.40%)
Flexion Therapeutics (FLXN) Upgraded to Buy: What Does It Mean for the Stock?

Flexion Therapeutics (FLXN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

FLXN : 11.99 (-1.40%)
Flexion Therapeu Rises 1.96% on Heavy Volume: Watch For Potential Pullback

Flexion Therapeu (NASDAQ:FLXN) traded in a range yesterday that spanned from a low of $12.31 to a high of $12.64. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high...

FLXN : 11.99 (-1.40%)
Flexion Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the BMO 2020 Prescriptions...

FLXN : 11.99 (-1.40%)
Flexion Therapeu Has Returned 45.8% Since SmarTrend Recommendation (FLXN)

SmarTrend identified an Uptrend for Flexion Therapeu (NASDAQ:FLXN) on March 25th, 2020 at $7.68. In approximately 2 months, Flexion Therapeu has returned 45.83% as of today's recent price of $11.20.

FLXN : 11.99 (-1.40%)
Flexion Therapeu Rises 8.53% on Heavy Volume: Watch For Potential Pullback

Flexion Therapeu (NASDAQ:FLXN) traded in a range yesterday that spanned from a low of $10.39 to a high of $11.23. Yesterday, the shares gained 8.5%, which took the trading range above the 3-day high...

FLXN : 11.99 (-1.40%)
Flexion (FLXN) Soars: Stock Adds 6.6% in Session

Flexion (FLXN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

FLXN : 11.99 (-1.40%)
ATXI : 9.76 (+0.10%)
Flexion Therapeutics Announces Pricing of Public Offering of Common Stock

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the pricing of an underwritten public offering of 9,230,770 shares of its common stock at a price to the public of $9.75 per share. The gross proceeds...

FLXN : 11.99 (-1.40%)
Flexion Therapeutics Announces Proposed Public Offering of Common Stock

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten public offering of $75,000,000 of shares of its common stock. Flexion also expects to grant the underwriters...

FLXN : 11.99 (-1.40%)
How Flexion Therapeutics (FLXN) Stock Stands Out in a Strong Industry

Flexion Therapeutics (FLXN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

FLXN : 11.99 (-1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade FLXN with:

Business Summary

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United...

See More

Key Turning Points

2nd Resistance Point 12.36
1st Resistance Point 12.17
Last Price 11.99
1st Support Level 11.84
2nd Support Level 11.70

See More

52-Week High 22.98
Fibonacci 61.8% 16.12
Fibonacci 50% 13.99
Last Price 11.99
Fibonacci 38.2% 11.87
52-Week Low 5.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar